Algernon Pharmaceuticals Inc.
Symbol:
CSE: AGN
OTCQB: AGNPF
Market Cap:
Private
Sector:
Healthcare
Summary:
Clinical Stage Drug Development Company
Projecting Phase 2 Data – Q2, 2022 for Idiopathic Pulmonary Fibrosis & Chronic Cough Study
Lead Program Includes Investigating the Psychedelic Drug DMT for Stroke